Innospec (US.IOSP)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.IOSP · YoY: 2026 Q1 vs 2025 Q1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 20.5% | ↓ |
| ROE | 2.3% | ↓ |
| Cash Conversion | 57.9% | ↓ |
| D/E Ratio | 0.04 | ↓ |
| Gross Margin | 27.3% | → |
US.IOSP (Innospec) | YoY: 2026 Q1 vs 2025 Q1 Metric Value YoY --------------------------- FCF Conversion 20.5% ↓ ROE 2.3% ↓ Cash Conversion 57.9% ↓ D/E Ratio 0.04 ↓ Gross Margin 27.3% →
Key Metrics
US.IOSP (Innospec) | YoY: 2026 Q1 vs 2025 Q1
Metric Value YoY---------------------------FCF Conversion 20.5% ↓ROE 2.3% ↓Cash Conversion 57.9% ↓D/E Ratio 0.04 ↓Gross Margin 27.3% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies